Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 35, 2022 - Issue 6
34
Views
0
CrossRef citations to date
0
Altmetric
Case Studies

Malignant mixed epithelial and stromal tumor of the kidney with rhabdomyosarcomatous transformation presenting with gross hematuria

, DO, MScORCID Icon, , MD & , MD
Pages 837-839 | Received 13 May 2022, Accepted 06 Jun 2022, Published online: 05 Jul 2022
 

Abstract

Malignant rhabdomyosarcoma associated with mixed epithelial and stromal tumor of the kidney (MESTK) is an exceptionally rare clinical phenomenon, with only two reported cases. Here, we describe the case of a middle-aged Middle Eastern woman with a left renal mass diagnosed as malignant MESTK with rhabdomyosarcomatous transformation. The patient initially presented with gross hematuria and was found to have a heterogenous 6.3 × 4.0 cm left renal mass, initially suspected to be renal cell carcinoma. She underwent nephrectomy with surgical resection of the tumor. Microscopic exam revealed neoplastic tissue composed of spindle and epithelial cells. The immunohistochemical analysis revealed positive staining for desmin, SMA, PR and negative staining for EMA, HMB 45, Melan A, and ER, consistent with MESTK with malignant rhabdomyosarcomatous transformation. The patient’s whole-body positron emission tomography/computed tomography revealed no residual malignancy, and the patient currently remains under clinical observation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.